SCHEMBL7682340

SCHEMBL7682340

CCOC(=O)CCN1CCN(C2c3ccccc3CCc3ccccc32)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 1/20 0.47
TMEM97 Q5BJF2 4/20 0.46
SIGMAR1 Q99720 4/20 0.46
NOTUM Q6P988 1/20 0.46
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
TSHR P16473 1/20 0.45
CYP2C19 P33261 1/20 0.45
HTT P42858 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
SLC6A2 P23975 2/20 0.44
HRH2 P25021 2/20 0.44
HRH1 P35367 2/20 0.44
HTR2C P28335 2/20 0.44
HTR1A P08908 1/20 0.44
CHRM5 P08912 1/20 0.44
ADRA1D P25100 1/20 0.44
HTR1B P28222 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7675822 0.93 P2RX7 (0.50) P2RX7TMEM97SIGMAR1NOTUMCYP1A2
SCHEMBL7681311 0.88 TSHR (0.55) P2RX7NOTUMCYP1A2CYP3A4CYP2D6
SCHEMBL7682336 0.82 P2RX7 (0.52) P2RX7HTTL3MBTL1HTR2CHTR1A
Hydrochloric Acid SCHEMBL7672600 0.81 P2RX7 (0.51) P2RX7HTTL3MBTL1HTR2CHTR1A
SCHEMBL7678668 0.80 P2RX7 (0.51) P2RX7CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL14033021 0.80 NOTUM (0.42) NOTUMCYP1A2L3MBTL1
SCHEMBL7672812 0.78 P2RX7 (0.56) P2RX7SIGMAR1HRH1HTR2CHTR1A
Hydrochloric Acid SCHEMBL7675560 0.77 P2RX7 (0.55) P2RX7SIGMAR1HRH1HTR2CHTR1A
SCHEMBL7681242 0.77 P2RX7 (0.55) P2RX7SIGMAR1HTR2CHTR1ASLC6A3
Hydrochloric Acid SCHEMBL7673708 0.76 P2RX7 (0.54) P2RX7SIGMAR1HTR2CHTR1ASLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020151539-A1 Novel heterocyclic compounds JORGENSEN TINE KROGH (DK) 2002-10-17 US disclosed
US-6391890-B1 ANALGESICS, ANTIINFLAMMATORY AGENTS, NON-INSULIN DEPENDENT DIABETES NOVO NORDISK A/S (DK) 2002-05-21 US disclosed
US-6054458-A Heterocyclic compounds NOVONORDISKALS (DK) 2000-04-25 US disclosed
EP-0991633-A1 NOVEL HETEROCYCLIC COMPOUNDS NOVO NORDISK A/S (DK) 2000-04-12 EP disclosed
WO-1999000376-A1 NOVEL HETEROCYCLIC COMPOUNDS NOVO NORDISK A/S (DK) 1999-01-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020151539-A1 Novel heterocyclic compounds IAPP, GPR119, NPY1R P2RX7 68/4885TMEM97 1828/4885SIGMAR1 60/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.